|Last Updated: September 21, 2019 @ 9:13 am|
|Stability:||Ambient: 2 Hour(s); Refrigerated: 1 Day(s); Frozen: 12 Month(s); Incubated: Unacceptable|
|Interpretive Data:||General Reference Range : <0.010 ng/mL|
Troponin T values > or =0.01 ng/mL are a prognostic sign in patients with ischemic heart disease and most other situations. Clinical judgment is necessary to distinguish patients who have ischemic heart disease from those who do not. However, all patients with > or =0.01 ng/mL troponin T are at increased risk for cardiac events relative to patients with undetectable troponin T.
As with all markers of cardiac injury, elevations of troponin T do not in and of themselves indicate the presence of an ischemic mechanism. Many other disease states are associated with elevations of troponin T via mechanisms different from those that cause injury in patients with acute coronary syndromes. These include trauma (eg, contusion, ablation, or pacing), congestive heart failure, hypertension, hypotension (often with arrhythmias), pulmonary embolism, renal failure, and myocarditis.
Biotin in specimens taken from patients on high-dose biotin therapy or supplements may intefere with this test and cause inaccurate test results. It is recommended that for patients receiving therapy with high biotin doses (> 5 mg/day), no laboratory test specimen should be collected until at least 8 hours after the last biotin administration.